Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study

Overview

Journal Can J Hosp Pharm

Date 2016 Sep 14

PMID 27621490

Citations 5

Authors

Merisa Mok

Angus Kinkade

Anthony Tung

Aaron M Tejani

Affiliations

Soon will be listed here.

Citing Articles

Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention for Gram-Negative Bacteremia.

Ventres J, Ting M, Parente D, Rogers R, Norris A, Benitez G Open Forum Infect Dis. 2024; 11(9):ofae477.

PMID: 39263216 PMC: 11389609. DOI: 10.1093/ofid/ofae477.

Assessment of Intravenous versus Oral Antimicrobials in a Large Regional Health Authority.

Dulku M, Sekhon T, Tejani A Can J Hosp Pharm. 2022; 75(2):108-112.

PMID: 35387377 PMC: 8956462. DOI: 10.4212/cjhp.v75i2.3173.

Short and Concise Peer-to-Peer Teaching-Example of a Successful Antibiotic Stewardship Intervention to Increase Iv to Po Conversion.

Wild J, Siegrist B, Hobohm L, Munzel T, Schwanz T, Sagoschen I Antibiotics (Basel). 2022; 11(3).

PMID: 35326866 PMC: 8944614. DOI: 10.3390/antibiotics11030402.

Implementation of pharmacist-managed early switch from intravenous to oral therapy using electronic identification at a tertiary academic hospital.

Babonji A, Darwesh B, Al-Alwai M Saudi Pharm J. 2021; 29(4):324-336.

PMID: 33994827 PMC: 8093584. DOI: 10.1016/j.jsps.2021.03.006.

Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies.

Downen J, Jaeger C BMJ Open Qual. 2020; 9(1).

PMID: 31986120 PMC: 7011893. DOI: 10.1136/bmjoq-2019-000804.

References

Ho B, Lau T, Balen R, Naumann T, Jewesson P . The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study. BMC Health Serv Res. 2005; 5:48. PMC: 1185535. DOI: 10.1186/1472-6963-5-48. View

Sallach-Ruma R, Nieman J, Sankaranarayanan J, Reardon T . Correlates and Economic and Clinical Outcomes of an Adult IV to PO Antimicrobial Conversion Program at an Academic Medical Center in Midwest United States. J Pharm Pract. 2014; 28(3):238-48. DOI: 10.1177/0897190013516367. View

Lau B, Pinto B, Thiemann D, Lehmann C . Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake. Clin Ther. 2011; 33(11):1792-6. DOI: 10.1016/j.clinthera.2011.09.030. View

Beique L, Zvonar R . Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients. Can J Hosp Pharm. 2015; 68(4):318-26. PMC: 4552233. DOI: 10.4212/cjhp.v68i4.1472. View

Kuti J, Le T, Nightingale C, Nicolau D, Quintiliani R . Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm. 2002; 59(22):2209-15. DOI: 10.1093/ajhp/59.22.2209. View